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Abstract 
Behaviours associated with agitation are common in people living with dementia. The 
Cohen-Mansfield Agitation Inventory (CMAI) is a 29-item scale widely used to assess 
agitation completed by a proxy (family carer or staff member). However, proxy informants 
introduce possible reporting bias when blinding to the treatment arm is not possible, and 
potential accuracy issues due to irregular contact between the proxy and the person with 
dementia over the reporting period. An observational measure completed by a blinded 
researcher may address these issues, but no agitation measures with comparable items exist. 
This study developed and validated observational version of the CMAI (CMAI-O) and 
assessed its validity as an alternative or complementary measure of agitation. We recruited 
726 participants with dementia from 50 care homes as part of a clinical trial. The CMAI-O 
and an additional observational measure of agitation (Pittsburgh Agitation Scale; PAS) were 
completed. Measures of agitation, functional status, and neuropsychiatric symptoms were 
completed with staff proxies. The CMAI-O showed adequate internal consistency (α = .61), 
criterion validity with the PAS (r = .79, p = <.001), incremental validity in predicting quality 
of life beyond the Functional Assessment Staging of Alzheimer’s disease (β = 1.83, p < .001 
at baseline) and discriminant validity from the Neuropsychiatric Inventory Apathy subscale 
(r = .004, p = .902). The CMAI-O is a promising research tool for independently measuring 
agitation in people with dementia in care homes. Its use alongside the CMAI could provide a 
more robust understanding of agitation amongst residents with dementia. 
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Validation of the Cohen-Mansfield Agitation Inventory Observational (CMAI-O) Tool 
Behaviours associated with agitation are common amongst people living with dementia, 
particularly in care home settings with prevalence estimates of clinically significant 
symptoms ranging from 40-85% in various countries including the UK, Norway, and Holland 
(Livingston et al., 2017; Testad et al., 2007; Zuidema et al., 2007). The aetiology of agitation 
is not clear but is likely to be multifactorial with care approaches, the physical and social 
environment, medical comorbidities such as pain, genetics and the progression of dementia 
pathology all being contributing factors (Lanctôt et al., 2017). Consistent with its 
multifactorial aetiology, there are many behaviours typically associated with agitation 
including repetitive mannerisms, hoarding, screaming, hitting, wandering, verbal aggression, 
and general restlessness, which can be extremely distressing to the person with dementia, 
their carers and others around them. Recent consensus criteria for agitation state that 
symptoms of agitation should: 1) occur in the context of cognitive impairment of dementia; 
2) be consistent with emotional distress; 3) manifest as excessive motor activity, verbal or 
physical aggression and 4) not be solely attributable to another disorder (Cummings et al., 
2015). While these criteria provide a useful and much needed framework for the assessment 
of agitation, particularly with respect to inclusion in clinical trials, there is still a need to 
refine and validate assessment tools to accurately evaluate agitation as a clinical outcome. 
The Neuropsychiatric Inventory (NPI; Cummings et al., 1994) and the Cohen-Mansfield 
Agitation Inventory (CMAI; Cohen-Mansfield et al., 1986) are both commonly used to 
evaluate agitation. The CMAI consists of 29 items forming four sub-scales; physically 
aggressive behaviour (e.g. hitting others), physically non-aggressive behaviour (e.g. pacing), 
verbally aggressive (e.g. swearing) and verbally non-aggressive behaviours (e.g. repetitive 
sentences). The CMAI incorporates both the frequency and severity of behaviours associated 
with agitation, and allows the quantification of agitated behaviours into a continuous 
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measure, which is sensitive to change. The combination of these factors has led to its 
widespread use in clinical trials of pharmacological (e.g. Porsteinsson et al., 2014) and 
psychosocial interventions (e.g. Ballard et al., 2018). 
Proxy informant interviews to complete outcome measures have clear benefits for 
populations of people with dementia, who are likely to have significant cognitive impairment 
or communication difficulties, which often make direct interviews difficult (Moyle et al., 
2007). Notable drawbacks include informant recall/knowledge (due to factors such as the 
amount of contact between the proxy and research participant during the reporting period) 
and – in the case of psychosocial interventions - lack of informant blinding to treatment both 
of which can affect measurement accuracy, increasing the chance of unwanted reporting 
error. In clinical trial settings, where there is an increasing number of clinical trials relating to 
agitation (e.g. Creese et al., 2018), and where close attention is being paid to the accuracy of 
outcome measurements and minimising placebo response rates, these drawbacks illustrate the 
need to explore alternative and complementary methods for outcome measurements. 
Observational tools are one avenue for addressing the issues outlined above, as independent 
observers (i.e. members of the research team who are not part of the intervention delivery) 
are able to remain blinded to treatment and are not subject to recall issues. There are a 
number of observational measures of agitation in people with dementia (Curyto et al., 2008, 
Zeller et al., 2010). However, some measure a broader range of behaviours that include but 
are not restricted to agitation (Auer et al., 1996; Beck et al., 1997; McCann et al., 1997; 
Morgan & Stewart, 1998; Van Haitsma et al., 1997), some are not appropriately validated 
(Camberg et al., 1999; Cohen-Mansfield et al., 1989; Yudofsky et al., 1997), or are not 
validated specifically for use with people with dementia, others include only a narrow range 
of agitated behaviours such as aggression (e.g. Almvik et al., 2008; Perlman & Hirdes, 2008) 
and others are not available (Whall, 1999).      
Validation of the CMAI-O 5 
 
 
 
There are then, few observational agitation measures appropriately validated for use with 
people with dementia, which include a range of potential agitated behaviours. These include 
Agitated Behaviour Scale (ABS; Bogner et al., 1999; Corrigan et al., 1989) and the Pittsburgh 
Agitation Scale (PAS; Rosen et al. 1994). However, these too have limitations. The ABS for 
example, was originally developed for use in people with traumatic brain injury and some 
items are relevant only to a hospital rather than care home environment (e.g. pulling at tubes, 
restraints etc). The scale also does not capture the frequency of occurrence of a particularly 
behaviour over an extended period of time due to the 20-minute observation periods used. 
The PAS measures the severity of four groups of agitated behaviours and is completed by 
trained researchers or clinical staff based on observations of participant behaviour over a shift 
or similar extended period of time. The PAS lacks detail in key areas including the breadth of 
symptoms assessed and the frequency with which symptoms occur. These additional pieces 
of information are vital for any assessment scale to capture heterogeneous range of symptoms 
that can constitute an agitated clinical syndrome. Likewise, due to the different approaches to 
measurement of agitation, none of the measures are appropriate for use as a direct comparator 
measure to the CMAI to detect potential reporting error by proxy reporters.    
We sought to address these issues by developing and testing an observational version of the 
CMAI and including it in a randomized controlled trial where the primary outcome measure 
was resident agitation measured by the CMAI. This paper presents data that evaluates the 
psychometric properties and reliability of the CMAI-O and its criterion, incremental and 
discriminant validity in comparison to existing measures. It also discusses its potential as an 
alternative or complementary measure of agitation in people with dementia. This was 
Validation of the CMAI-O 6 
 
achieved through secondary analysis of the [name redacted] trial dataset (see Surr et al., 2016 
for trial protocol). 
Method 
Participants 
Participants [number (N) = 726] were recruited from 50 randomly selected care homes (mean 
= 15 residents per care home) in three regions across England (Yorkshire, Oxfordshire and 
London) for a randomized controlled trial. Residents were eligible to participate if they lived 
in the care home permanently and had a formal diagnosis of dementia or scored ≥4 on the 
Functional Assessment Staging of Alzheimer’s disease (FAST; Reisberg, 1988). Residents 
were ineligible to participate if they had been formally admitted to an end of life care 
pathway or were cared for in bed.  
For inclusion in the present work, participants were required to have the CMAI-O (completed 
by an independent observer) completed for at least two hours, and at least one measure 
completed by a staff proxy. Therefore, the sample differed at each time point due to loss to 
follow-up and missing data. 
A staff proxy was recruited for each participant, who was an individual who knew the 
resident well. To be eligible as a staff proxy, the individual was required to have a permanent 
contract in the care home and have known the resident well (as assessed by their key worker 
status and/or the judgement of the home manager) for at least several months. Additionally, 
this person must have been in regular contact with the resident during the previous two 
weeks. Researchers provided information on the completion of measures, including the 
period that the staff proxy should consider, and the use of rating scales. 
Where possible, residents provided consent to participate. Where potential participants were 
deemed not to have capacity, a personal consultee (relative or friend) was approached to 
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provide advice on the person’s wishes. For potential participants whose personal consultee 
did not respond to contact or who did not have anyone to act as a personal consultee, a 
nominated consultee (care staff member) was approached to provide this advice.  
Ethical considerationsEthical approval for the clinical trial was obtained from the [name 
removed for peer review] committee and subsequent ethical approval for this sub-study was 
obtained from the [name removed for peer review] committee. Where possible, residents 
provided informed written consent to participate. Where potential participants were deemed 
not to have capacity, in line with the Mental Capacity Act (2005) and following standard 
guidance (Medical Research Council, 2007) a personal consultee (relative or friend) was 
approached to provide advice on the person’s wishes. For potential participants whose 
personal consultee did not respond to contact or who did not have anyone to act as a personal 
consultee, a nominated consultee (care staff member) was approached to provide this advice. 
For reasons of privacy and dignity, CMAI-O and PAS observations took place only in the 
public areas of the care home (e.g. lounge, dining room, corridors) and no private or personal 
care, or observations in bedrooms or bathrooms were conducted. 
Measures 
Six measures were completed at three time points; baseline, 6-months post care home 
randomisation (first follow-up) and 16-months post randomisation (second follow-up), see 
Table 1 for an overview. The independent observer, who was blinded to intervention 
allocation, conducted observations (of both the CMAI-O and PAS) between approximately 
10am and 12pm, and 2pm and 5pm, on a single day, to reach a total of 5 hours observation. 
All other measures, completed by a researcher with the staff proxy, were completed within 
four weeks of the observational measures. 
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Researchers were able to act as the independent observer if they had not previously visited 
the care home to consent participants or complete any data collection. Prior to this, inter-rater 
reliability with another researcher of at least 80% agreement on the CMAI-O over a one-hour 
period was required.  
INSERT TABLE 1 HERE 
Cohen-Mansfield Agitation Inventory 
The CMAI (Cohen-Mansfield & Billig, 1986) measures 29 behaviours typically associated 
with agitation or aggression. Proxy reporters identify the frequency of 29 behaviours during 
the past two weeks, on a seven-point Likert scale ranging from “never” to “several times an 
hour”, with higher scores indicating more agitation. The measure has moderate concurrent 
validity with NPI-NH Agitation sub-scale (r = .52; Wood et al., 2000) and converge with an 
observational scale of agitation, the Agitated Behaviours Mapping Instrument (r = .32-.39; 
Cohen-Mansfield & Libin, 2004). The CMAI showed internal consistency of α = .85 at 
baseline.  
Observational Cohen-Mansfield Agitation Inventory (CMAI-O) 
The CMAI-O includes the same 29 items as the CMAI, but completed through observations 
of the participant by a trained researcher. The CMAI-O is scored on a four-point Likert scale 
of 1 “never”, 2 “less than once per hour”, 3 “once per hour” and 4 “several times an hour”, 
with higher scores indicating more agitation. In the present study, data were collected across 
five hours split into two time points during a single day. Up to fifteen observations 
(individuals) were conducted simultaneously. The CMAI-O showed internal consistency of α 
= .61 at baseline. 
Pittsburgh Agitation Scale (PAS) 
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The PAS (Rosen et al., 1994) is an observational rating of agitation and was completed by the 
independent observer concurrently with the CMAI-O. This measures intensity of agitation on 
four domains; aberrant vocalization (e.g. screaming), motor agitation (e.g. wandering), 
aggressiveness, and resisting care, each scored on a five-point Likert scale from 0 (not 
present) to 4 (high intensity of agitated behaviour). The measures also asks whether any 
interventions were used by care staff to support or manage agitated behaviours e.g. seclusion, 
or restraint. PAS observations should be conducted for between one and eight hours, and in 
the present study, data were collected across five hours in a single day. The measure has 
internal consistency of α = .80 (Rosen et al., 1994) and in the current study, had internal 
consistency of α = .63 at baseline. 
 The Neuropsychiatric Inventory – Nursing Home (NPI-NH)  
The NPI-NH (Cummings, 1997; Cummings et al., 1994) identified psychopathology for 
people with dementia in care homes. It assesses the presence and occupational disruptiveness 
of twelve behaviours, such as agitation/aggression, anxiety, and disinhibition. The frequency 
(within the past two weeks) and severity of each behaviour are rated on a four-point (1–4) 
and three-point (1–3) Likert scale respectively. A score is then calculated for each behaviour 
by multiplying the severity and frequency score (1 – 12). A total score is then calculated by 
adding the scores of all twelve subscales. A composite score comprising agitation/aggression, 
irritability/lability, disinhibition and aberrant motor behaviour accounts for 60% of the 
variance of a total CMAI score (Wood et al., 2000). The measure showed internal 
consistency of α = .63 at baseline. 
Quality of Life in Late-Stage Dementia  
The Quality of Life in Late-Stage Dementia (QUALID) scale (Weiner et al., 2000) measures 
11 observable behaviours thought to indicate quality of life such as ‘enjoys interacting or 
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being with others’. Each behaviour is scored on a five-point Likert scale, lower scores 
indicate higher quality of life. The measure is based on observations made over the previous 
seven days. Scores previously correlated with the NPI (r = .40, p = .001; Weiner et al., 2000), 
although not the CMAI (r = .19, p > .05; Benhabib et al., 2013). The NPI-NH showed 
internal consistency of α = .74 at baseline. 
Functional Assessment Staging of Alzheimer’s Disease 
The Functional Assessment Staging of Alzheimer’s Disease (FAST; Reisberg, 1988) records 
how severely dementia affects individuals’ daily functioning. Scores range from 1 (no 
dementia) to 7 (severe dementia), with levels 6 and 7 having sub-levels, focusing on deficits 
associated with personal care and communication. It was completed by a researcher through 
interview with a staff proxy.   
Missing data  
The levels of missing data were relatively high by the second follow up (43.8%), due to loss 
to follow up across 16-months of the trial (see Table 2). During data analysis, missing data 
were identified and recoded before being incorporated or excluded from all analyses. For the 
incremental validity and discriminant validity analyses all missing data recorded from each 
scale were excluded from the analysis. When performing correlation analyses between the 
PAS and CMAI-O, multiple imputation was used (Rubin, 1987). This technique creates 
complete data sets by generating several possible values for any missing values. Analyses are 
conducted across all of these data sets and outputs provide estimates for each data set about 
the results that would have been expected if there had been no missing values in the original 
data set. In the present study, 5 data imputations were created. 
INSERT TABLE 2 HERE 
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Furthermore, the CMAI-O was only completed for participants who were in a communal area 
during data collection (either AM, PM, or both). The number of participants with completed 
CMAI-O at each time point and reasons why people were not in a communal area of the care 
home were recorded (see Table 3).  
INSERT TABLE 3 HERE 
Data Analysis 
Data manipulation, analyses and graphical visualisations were performed in IBM SPSS 24. 
Prior to performing inferential statistical analyses, each dataset was assessed for parametric 
assumptions. A skewed distribution was consistently observed across all data, suggesting that 
scores were predominantly weighted at the lower end of each scale. This was expected as the 
majority of residents within care homes score lowly on neuropsychiatric outcome measures; 
whilst only a minority of residents typically score highly. In order to account for this non-
normal data, parametric bootstrapping was performed on all analyses (see Davison & 
Hinkley, 1997). Data were deemed to meet all other parametric assumptions. 
Several forms of validity were tested; criterion validity, incremental validity and discriminant 
validity. Criterion validity refers to the degree of correlation between a proposed novel 
measure and a pre-existing, validated assessment that targets the same phenomenon. It is 
important that a new measure demonstrates criterion validity as it assures researchers and 
practitioners that any results derived can be assumed to be consistent with alternative 
methods of assessment. Incremental validity is used to determine whether a new measure 
increases the predictive ability beyond that provided by an existing tool. It is important to 
demonstrate this form of validity as it demonstrates that a measure elicits additional 
information relative to other measures. Discriminant validity illustrates whether scores on a 
scale are truly independent of scores on another scale that measures distinctly different 
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phenomena. Previous evidence has found no correlation between agitation and apathy in a 
sample of nursing home residents living with dementia (Mouriz-Corbelle et al., 2017). 
Therefore, we hypothesised that the CMAI-O would be unrelated to the NPI Apathy subscale 
if discriminant validity is high.  
Results 
Sample 
The baseline sample consisted of 726 participants, with an average age of 85 (range: 57-102). 
The majority of participants were female (536; 73.8%) and identified as White British (702; 
96.7%). Participant dementia severity, as rated by the FAST, spanned mild cognitive 
impairment (6; 1%), mild dementia (95; 13.6%), moderate dementia (74; 10.6%), 
moderate/severe dementia (380 ;54.5%) and severe dementia (142; 20.4%), with data missing 
for 29 participants (3.9%). The average score on the CMAI was 47.35 points (standard 
deviation = 18.40) and average score on the NPI was 14.18 (SD = 14.69). Of these 
participants, 451 (62%) had a completed CMAI-O for AM, and 470 (65%) for PM.  
At 6-months, the sample consisted of 587 participants. The average score on the CMAI was 
45.35 (standard deviation = 16.32). Of these participants, 369 (62%) had a completed CMAI-
O for AM and 357 (61%) for PM.  
At 16-months, the sample consisted of 408 participants. The average score on the CMAI was 
44.38 (standard deviation = 16.72). Of these participants, 231 (56%) had a completed CMAI-
O for AM and 221 (54%) for PM.  
Preliminary Analyses 
The prevalence of each symptom at baseline, measured using the CMAI and CMAI-O can be 
seen in Table 4. Within this Table, for the CMAI, only items that were present ‘several times 
a week’ or more were included, in order to be comparable with the CMAI-O. This is due to 
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the CMAI-O being completed during one single day; therefore, items that are displayed once 
per week or less were unlikely to be displayed during a single day observation. Generally, 
levels of agitation were lower for the CMAI-O, with the exception of ‘performing repetitious 
mannerisms’, which was seen more commonly. 
INSERT TABLE 3 HERE 
Correlations between the CMAI-O and the CMAI, PAS and NPI, at each time point were also 
conducted (see Table 5). Pearson correlations for the CMAI-O and the CMAI as scored by 
the staff proxy were significant: baseline r = .44, six months r = .23 and sixteen months r = 
.28 (all p < .001). The NPI Agitation subscale had a weak but statistically significant 
correlation with the CMAI-O at baseline and six months (r = .38, p = < .001 and r = .12, p = 
.021), however no significant correlation was found between the two measures at 16 months 
(r = .09, p = .199). Finally, both the AM and the PM scores for the PAS showed a significant 
correlation with total CMAI-O scores across all time points, with a significance of p = < .001. 
INSERT TABLE 5 HERE 
To understand whether scores on the CMAI-O were related to scores on another scale 
measuring agitation, correlations were calculated between this and the PAS. There is no 
existing evidence of validation of the CMAI and the PAS. Given the PAS is the only existing 
observational measure of agitation it was used to compare to the CMAI-O, to establish 
criterion validity. A partial correlation was completed with bootstrapping to account for non-
normally distributed data, controlling for the data collection time point (baseline/6 month 
follow up/16 month follow up) and the time of day (AM or PM) when both were completed. 
When controlling for time point and the time of day completed, a significant partial 
correlation was found (r = .80, p = <.001). 
Additionally, we compared CMAI-O scores to the NPI Agitation subscale. Whilst not an 
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observational measure, it represents a psychometric tool validated to measure agitation in 
nursing home residents, thus a significant correlation between this and the CMAI-O would 
support criterion validity. A partial correlation analysis of the CMAI-O and the NPI Agitation 
subscale, controlling for data collection time point, found a small but significant relationship 
between the measures (r = .24, p = <.001). 
To assess whether the CMAI-O increased the predictive ability beyond that provided by an 
existing method of assessment, we hypothesised that agitation as measured by the CMAI-O 
would predict quality of life as measured by the QUALID, above the prediction from scores 
on the FAST.  It has been suggested in previous studies that functional status significantly 
impacts the quality of life of a person living with dementia (e.g. Andersen et al., 2004) with 
those with more severe dementia experiencing poorer quality of life.  
In step one of a hierarchal multiple regression, scores on the FAST were included as a 
predictor of quality of life. The FAST score significantly predicted the quality of life score 
across all time points, baseline (β = .21, p < .001), 6 months (β = .202, p = .001) and 16 
months (β = .198, p = .006). In step two of the analysis, when the CMAI-O score was also 
included as a predictor, an R2 change of .095 (R2 = .139, F(2, 390) = 66.87, p <.001) was 
observed at baseline, an R2 change of .027 (R2 = .068, F(2, 286) = 33.7, p<.001) at 6-months 
and an R2 change of .042 (R2 = .082, F(2, 191) = 32.12, p<.001) at 16-months. The FAST 
remained significant at each of these time points also [6-months (β = 3.45, p = .001), 16-
months (β = 3.09, p = .002)]. These analyses demonstrated that the observational CMAI had 
incremental predictive value in the measurement of quality of life beyond levels that could be 
predicted by participants’ stage of dementia, as determined by functional status (FAST). 
To establish whether the CMAI-O failed to correlate with a measure that should be 
conceptually unrelated, bootstrapped correlation analyses between the CMAI-O and all NPI 
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subscales were conducted, controlling for the data collection time point. We hypothesized 
that the CMAI-O would show no relationship with the NPI Apathy subscale. No relationship 
was found between the CMAI-O and NPI Apathy subscales, when controlling for time point 
(r = .004, p = .902). This suggests that agitation as measured by the CMAI-O is completely 
unrelated to apathy, in line with previous research. 
Discussion 
The present study describes the development and validation of the CMAI-O. This tool 
assesses agitation over a shorter period than the original CMAI, can be completed by an 
independent observer rather than relying on proxy reports and therefore could form part of an 
agitation assessment battery for research, including clinical trials. 
The psychometric properties of the CMAI-O were examined. Scores on the CMAI-O 
correlated with scores on the CMAI, PAS and NPI-NH, and the tool had incremental 
predictive value when measuring quality of life beyond levels predicted by functional status. 
No relationship was found between the CMAI-O and NPI Apathy subscale, suggesting that 
agitation as measured by the CMAI-O is completely unrelated to apathy. The internal 
consistency of the CMAI-O, whilst being adequate, suggested that there may be issues with 
the items within the scale. Further examination of this is required, to establish whether this 
was caused by general low levels of agitation within our sample, or issues within the 
measure. Within the current study, we sought to assess the psychometric properties of an 
alternative method of administration, therefore we have not suggested refinement of the 
CMAI-O items.  
To identify whether the CMAI-O identified behaviours typically associated with agitation 
comparisons between the CMAI-O and CMAI were also conducted. Scores on the CMAI-O 
were consistently slightly lower than those on the CMAI. This may be due to the restricted 
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locations and time periods of observation. For example, observations took place in the 
communal areas therefore agitated behaviours in other areas were not recorded, in particular 
during personal care. Previously, personal care activities including bathing and toileting, 
particularly when initiated by a caregiver rather than the resident themselves, have been 
found to significantly increase agitation behaviours (Cohen-Mansfield et al., 1992). 
There are several limitations with the present research. One difficulty when using 
observational methods for assessing agitation is that many behaviours do not occur often, 
therefore long observations are sometimes required to detect behaviours. This is especially 
true for the less common behaviours like aggression, which are some of the most important in 
terms of impact on others (Cohen-Mansfield, 1996). A standardised period of five hours 
within a single day in this study provided data that was adequately correlated with alternative 
proxy measures and, therefore, is the recommended minimum observation period for use of 
the CMAI-O. Secondly, we recruited participants from 50 care homes in three areas of 
England, which may not represent average care homes across the UK. For example, those 
under admissions bans due to breaches of statutory regulations were not eligible to participate 
and those approached but not interested in taking part in research did not consent to take part. 
The levels of agitation seen in the present sample were lower than previous samples (e.g. 
Zuidema et al., 2007). This may reflect improved understanding of how to effectively manage 
behaviours associated with agitation by care home staff over recent years. Understanding 
these as a reflection of unmet needs rather than symptoms of dementia is becoming a more 
common approach and recent research has found lower levels of agitation amongst people 
living with dementia in care homes (Livingston et al., 2017). Furthermore, the average CMAI 
score in the present study was similar to that of participants in another recent psychosocial 
clinical trial (Ballard et al., 2016). However, comparing levels of agitation in this study to 
those reported in earlier care home studies identified lower levels in this sample generally. 
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For example, 16% of individuals experienced general restlessness, in comparison to 44% of 
individuals in the Netherlands (Zuidema et al., 2007), although our sample was comparable to 
the 22% of individuals who experienced general restlessness within a Norwegian sample 
(Testad et al., 2007). However, it may be that given the relationship between agitation and 
poor quality care, individuals living in care homes where there are breaches of statutory 
regulations, such as unsafe staffing levels, might experience greater levels of agitation, and 
such individuals were not recruited in the present study as their care homes were ineligible to 
participate. Additionally, we only observed participants in communal areas, which may have 
impacted on levels of agitation. This may be particularly relevant as some of the measures 
completed by staff proxy informants included specific questions about personal care, which 
are not observed due to issues around privacy and dignity. 
By developing the CMAI-O we have addressed the disadvantage of the CMAI relating to 
potential reporting biases from proxy reporters. However, observational measures of agitation 
also have limitations. Levels of agitation observed by the CMAI-O were generally lower than 
those reported by care staff members in the CMAI, although scores on the two were 
significantly correlated. It may be that staff proxies over-report the prevalence of these 
behaviours on the CMAI, particularly if they find the behaviours difficult to support. 
Alternatively the CMAI-O may miss some agitation due to its use in this study only in 
communal areas during the daytime. Research indicates higher levels of agitation may be 
seen in the evenings and during personal care (e.g. Sloane et al., 2004). However, the CMAI-
O does have the benefit of using continual observation over two sustained periods which may 
offer a more accurate picture of agitation than measures that use short time-sampling 
observations. Additionally, observer fatigue is a concern with longer observation periods and 
one which should be considered.  Therefore, further research on optimal observation length 
and time(s) of day when using the CMAI-O is required, as well as exploration of ethical and 
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practical issues around the potential for observations to be conducted in other areas where 
care may be delivered. Researchers have rightly questioned the accuracy of recall of agitated 
behaviours by staff members working in care homes, due to the impact of caregiver burden. 
Care staff reporting lower burden have been found to provide higher quality of life ratings 
than those experiencing more caregiver burden (Graske et al., 2014). One possible 
explanation for this is that care staff experiencing burden also expect residents to be 
experiencing this burden (Graske et al., 2014). Alternatively, it may be that those 
experiencing burden are less able to see positive aspects of residents’ lives. However, there is 
currently very little research examining this amongst formal care staff. A systematic review 
of the relationship between family caregiver distress and quality of life ratings concluded that 
family caregivers who reported experiencing more stress associated with caregiving provided 
more negative reports of their relative’s quality of life (Neumann et al., 2000). However, 
more recently no relationship has been found between family caregiver distress and their 
proxy quality of life ratings (Sheehan et al., 2012). Furthermore, there is scope for influence 
by interpretation or perceptual biases of individual proxies. For example, a resident whose 
physical mobility has improved following an exercise intervention and who is spending more 
time walking may be noted as ‘wandering’ (Brett et al., 2017) by care home staff. This may 
be due to a perception that residents who are not sitting are more problematic to care for, or 
that ‘wandering’ is a common problem in dementia and therefore all walking behaviours 
must be wandering. Perceiving or interpreting this behaviour as wandering would indicate an 
increase in agitation when completing the CMAI, when the behaviour is instead walking that 
reflects an increase in physical ability and activity. Use of the CMAI-O, by trained 
researchers who receive instruction on how to observe and interpret resident behaviours may 
allow a more objective understanding of the behaviour of individuals, through concentrated 
observation of them over a substantial period of time. This may provide a more accurate 
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measure of agitation than untrained staff recall of behaviours over the previous two weeks. 
Future research should consider the influence of proxy reporters and their subjective 
experiences on research outcomes. 
Furthermore, a single researcher can complete the CMAI-O for multiple participants over 
several time points, whereas it is particularly difficult to recruit staff proxies for multiple time 
points, based on turnover and shift patterns. In addition the use of staff proxies to report on 
agitation of a two-week period raises concerns about accuracy reporting, since they work 
shifts and even when on duty do not always spend long periods of time with individual 
residents. Therefore, assumptions about frequency of agitated behaviours may be made on 
based on intensity over a short period or reports of disruptiveness from colleagues. In one 
recent study, to overcome this, staff members completed a tally score of the CMAI at the end 
of each shift for a two-week period (Brett et al., 2017). The CMAI-O addresses this potential 
reporting bias, as a researcher captures all behaviours across a single day, leading to 
decreased likelihood of over or under-reporting of agitated behaviours. However, observation 
on a single day does limit ability to observe less common but potentially impactful 
behaviours and therefore, further research is needed to examine the test-retest reliability of 
the CMAI-O and establish the optimal periods over which to use the measure to most 
accurately capture the full extent and range of agitated behaviours. Future research should 
also extend the validation of the CMAI-O to confirm the factor structure of the measure 
amongst individuals experiencing higher levels of agitation and establish whether it is 
suitable for use in other settings, such as hospital wards, or with other populations such as 
individuals living with severe and enduring mental health problems, where agitation is a 
concern.  
The CMAI-O offers a novel approach for evaluating the presence of behaviours associated 
with agitation amongst people with dementia in care homes (both residential and nursing) 
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within research and practice. The CMAI-O may be particularly useful to include in research 
where the CMAI is the primary outcome, since it may provide a measure of potential 
performance or reporting bias from staff members who cannot be blinded to treatment arm. 
Moreover, as an observational measure of agitation, the CMAI-O offers a more suitable 
observational measure than the PAS or ABS because its items are directly aligned to the 
CMAI and thus the results are complementary to those obtained on the CMAI. As such, 
future researchers will be able to confidently provide composite CMAI scores using 
information from both proxy-informant and researcher observations. 
Conclusion 
In conclusion, this initial validation of the CMAI-O has demonstrated that the tool is 
appropriate for use with people living with dementia in care homes. The tool provides a 
complementary or alternative to measure to staff proxy completed measures of agitation. This 
may be particularly valuable when evaluating care home interventions. It is hoped that the 
development of the CMAI-O leads to increased use of independent assessment to understand 
behaviours associated with agitation amongst people living with dementia in care homes and 
its use as an outcome measure to evaluate change in agitation. 
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Table 1. Overview of measures and use within the study 
Measure  Number of 
items 
Completed by Reporting 
period 
Form of 
validity/reliability 
used to test 
CMAI 29 Researcher with 
family/staff proxy  
Previous 2 
weeks 
 
Criterion 
CMAI-O 29 Independent 
observer 
Five hours on 
a single day  
N/A 
PAS 4 Independent 
observer 
Five hours on 
a single day 
Criterion 
 
 
NPI-NH 12 (with sub 
scales) 
Researcher with 
staff proxy 
Previous 2 
weeks 
 
Criterion 
Discriminant 
 
QUALID 11 Researcher with 
family/staff proxy 
Previous 7 
days 
Criterion 
 
 
FAST 7 levels (sub-
levels for levels 
6 and 7) 
Researcher with 
staff proxy 
Not specified Incremental 
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Table 2. Loss to follow up (of 726 registered residents at baseline) 
 6 months 16 months 
CMAI questionnaire (staff proxy completed) 
  Received 587 (80.9%) 408 (56.2%) 
Not received 139 (19.1%) 318 (43.8%) 
Reasons not received   
Died 115 (15.8%) 264 (36.4%) 
Moved out 21 (2.9%) 51 (7%) 
Withdrew 1 (0.1%) 1 (0.1%) 
Other 9 (1.2%) 3 (0.4%) 
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Table 3. Completion rates for Cohen Mansfield Agitation Inventory-Observational and reasons for non-completion (of all 726 registered 
residents) 
 
Baseline 6 months 16 months 
CMAI-O AM PM AM PM AM PM 
Completed Yes 451 (62.1%) 470 (64.7%) 369 (50.8%) 357 (49.2%) 231 (31.8%) 221 (30.4%) 
 
No 246 (33.9%) 226 (31.1%) 221 (30.4%) 233 (32.1%) 183 (25.2%) 193 (26.6%) 
 
Missing (includes individuals 
who died, withdrew and left 
care home) 
29 (4.0%) 30 (4.1%) 136 (18.7%) 136 (18.7%) 312 (43.0%) 312 (43.0%) 
If not completed, reasons (% out of 
not completed):        
Resident not in communal area 240 (97.6%) 221 (97.8%) 210 (95.0%) 217 (93.1%) 180 (98.4%) 187 (96.9%) 
Resident did not wish to be observed 1 (0.4%) - - - - - 
In hospital 2 (0.8%) 2 (0.9%) 7 (3.2%) 7 (3.0%) 3 (1.6%) 3 (1.6%) 
Missing 2 (0.8%) 1 (0.4%) 2 (0.9%) 6 (2.6%) - 3 (1.6%) 
Other 1 (0.4%) 2 (0.9%) 2 (0.9%) 3 (1.3%) - - 
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Table 4. Proportion of residents experiencing symptoms associated with agitation at baseline 
(% of those with both Cohen Mansfield Agitation Inventory-Observational and Cohen 
Mansfield Agitation Inventory completed) 
Symptom CMAI-O CMAI 
Pacing, aimless wandering 15 32 
Inappropriate dress or disrobing 2 11 
Spitting (including at meals) 1 7 
Cursing/verbal aggression 8 14 
Constant unwarranted request for 
attention/help 
4 15 
Repetitive sentences/questions 9 27 
Hitting (including self) 1 8 
Kicking 1 6 
Grabbing onto people 2 10 
Pushing 2 6 
Throwing 1 3 
Strange noises (weird laughter or crying) 11 13 
Screaming 1 10 
Biting 1 2 
Scratching 1 6 
Trying to get to a different place 3 10 
Intentional falling 1 1 
Complaining 10 14 
Negativism 4 11 
Eating/drinking inappropriate substances 1 2 
Hurting self or others 1 1 
Handling things inappropriately 4 4 
Hiding things 0 5 
Hoarding things 1 4 
Tearing things/destroying property 1 2 
Performing repetitious mannerisms 22 15 
Making verbal sexual advances 1 2 
Making physical sexual advances 1 1 
General restlessness 16 24 
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Table 5. Correlation between measures completed at each time point 
 
  
 
 
 
CMAI-O 
 
 
 Baseline 6 months 16 months 
 
CMAI 
 
 
.436* 
 
.226* 
 
.276* 
 
 
NPI 
(Agitation) 
 
 
.382*  
 
.121* 
 
.085 
 
PAS (AM) 
 
 
.583* 
 
.825* 
 
.770* 
 
PAS (PM) 
 
 
.638* 
 
.479* 
 
.540* 
 
* significant at p < 0.01 
**CMAI-O – Cohen-Mansfield Agitation Inventory – Observational; CMAI – Cohen Mansfield 
Agitation Inventory; NPI – Neuropsychiatric Inventory; PAS – Pittsburgh Agitation Scale 
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